OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9480	Companies
185559	Keywords
117951	Articles
99390	Press releases

Home
Companies
OXURION

BRIEF

published on 07/17/2025 at 08:35, 4 months 19 days ago

Oxurion obtient un financement pour une acquisition majeure

Acquisition Biopharmaceutique Données Cliniques Oxurion Plateforme Européenne
BRIEF

published on 07/17/2025 at 08:35, 4 months 19 days ago

Oxurion Secures Financing for Major Acquisition

Acquisition Biopharmaceutical Clinical Data Oxurion Europe Hub
BRIEF

published on 07/17/2025 at 08:35, 4 months 19 days ago

Oxurion Sécurise le Financement pour l'Acquisition d'Axiodis CRO

Acquisition Biopharmaceutique Données Cliniques Oxurion Axiodis CRO
PRESS RELEASE

published on 07/17/2025 at 08:30, 4 months 19 days ago

Oxurion verzekert financiering voor de overname van Axiodis CRO en beoogt een closing op 1 augustus 2025
Oxurion sichert Finanzierung für die Übernahme von Axiodis CRO ab und plant Abschluss der Transaktion am 1. August 2025

Übernahme Finanzierung Oxurion Klinische Daten Therapeutische Entwicklung
PRESS RELEASE

published on 07/17/2025 at 08:30, 4 months 19 days ago

Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025
Oxurion NV secures financing for 72% stake in Axiodis CRO, enhancing its clinical data capabilities. Acquisition aligned with strategic roadmap for European hub. Closing set for August 1, 2025

Acquisition Clinical Data Oxurion NV Axiodis CRO European Hub
BRIEF

published on 07/15/2025 at 18:05, 4 months 21 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Shares Transparency Atlas Biopharmaceutical Oxurion
BRIEF

published on 07/15/2025 at 18:05, 4 months 21 days ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actions Atlas Transparence Biopharmaceutique Oxurion
PRESS RELEASE

published on 07/15/2025 at 18:00, 4 months 21 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV meldt ontvangst van transparantiekennisgeving en verlaagd aandelenposities onder wettelijke drempel. Biofarmaceutisch bedrijf in Leuven actief op gebied van therapeutische innovatie en klinisch onderzoek

Transparantiekennisgeving Euronext Brussel Oxurion NV Leuven Biofarmaceutisch
PRESS RELEASE

published on 07/15/2025 at 18:00, 4 months 21 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian Transparency legislation

Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
BRIEF

published on 07/14/2025 at 18:05, 4 months 22 days ago

Oxurion annonce les notifications de transparence d'Atlas

Biopharmaceutique Notification Aux Actionnaires Oxurion NV Opportunités Spéciales Atlas Législation Sur La Transparence

Accesswire

Published on 12/05/2025 at 21:45, 1 hour 5 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 1 hour 20 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 1 hour 30 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour 50 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 2 hours 25 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 35 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 38 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 3 hours 52 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 4 hours 24 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 4 hours 35 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 17:18, 5 hours 32 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 5 hours 32 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 7 hours 39 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 7 hours 39 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 52 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE